236 related articles for article (PubMed ID: 19254210)
1. [Rosuvastatin and fenofibrate in patients with diabetes and low high density lipoprotein cholesterol: comparison of changes of lipid levels and some markers of inflammation].
Polenova NV; Vaulin NA; Masenko VP; Iavelov IS; Gratsianskiĭ NA
Kardiologiia; 2009; 49(2):9-14. PubMed ID: 19254210
[TBL] [Abstract][Full Text] [Related]
2. [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].
Sergienko IV; Samoĭlenko EIu; Masenko VP; Ezhov MV; Sumarokov AB; Tkachev GA; Pogorelova OA; Balakhonova TV; Naumov VG
Kardiologiia; 2006; 46(5):4-8. PubMed ID: 16858347
[TBL] [Abstract][Full Text] [Related]
3. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.
Agouridis AP; Tsimihodimos V; Filippatos TD; Dimitriou AA; Tellis CC; Elisaf MS; Mikhailidis DP; Tselepis AD
Expert Opin Pharmacother; 2011 Dec; 12(17):2605-11. PubMed ID: 21714585
[TBL] [Abstract][Full Text] [Related]
4. Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe.
Yamazaki D; Ishida M; Watanabe H; Nobori K; Oguma Y; Terata Y; Koyama T; Iino K; Kosaka T; Ito H
Lipids Health Dis; 2013 Feb; 12():9. PubMed ID: 23374898
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial.
Kei A; Liberopoulos E; Tellis K; Rizzo M; Elisaf M; Tselepis A
Eur J Clin Invest; 2013 Jul; 43(7):698-707. PubMed ID: 23600368
[TBL] [Abstract][Full Text] [Related]
6. Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Lee SH; Cho KI; Kim JY; Ahn YK; Rha SW; Kim YJ; Choi YS; Choi SW; Jeon DW; Min PK; Choi DJ; Baek SH; Kim KS; Byun YS; Jang Y
Atherosclerosis; 2012 Mar; 221(1):169-75. PubMed ID: 22269152
[TBL] [Abstract][Full Text] [Related]
7. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Ferdinand KC; Davidson MH; Kelly MT; Setze CM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein cholesterolaemia.
Katabami T; Murakami M; Kobayashi S; Matsui T; Ujihara M; Takagi S; Higa M; Ichijo T; Ohta A; Tanaka Y
J Int Med Res; 2014 Apr; 42(2):457-67. PubMed ID: 24595147
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
[TBL] [Abstract][Full Text] [Related]
10. Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
Rosenson RS; Carlson DM; Kelly MT; Setze CM; Hirshberg B; Stolzenbach JC; Williams LA
Cardiovasc Drugs Ther; 2011 Feb; 25(1):47-57. PubMed ID: 21174145
[TBL] [Abstract][Full Text] [Related]
11. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
Kuznetsova MA; Vaulin NA; Masenko VP; Gratsianskiĭ NA
Kardiologiia; 2010; 50(2):21-5. PubMed ID: 20146674
[TBL] [Abstract][Full Text] [Related]
12. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
[TBL] [Abstract][Full Text] [Related]
13. Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
Pepine CJ; Jacobson TA; Carlson DM; Kelly MT; Setze CM; Gold A; Stolzenbach JC; Williams LA
Clin Cardiol; 2010 Oct; 33(10):609-619. PubMed ID: 20960535
[TBL] [Abstract][Full Text] [Related]
14. High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.
Agouridis AP; Tsimihodimos V; Filippatos TD; Tselepis AD; Elisaf MS
Lipids; 2011 Jun; 46(6):521-8. PubMed ID: 21327725
[TBL] [Abstract][Full Text] [Related]
15. Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.
Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
J Atheroscler Thromb; 2011; 18(11):1018-28. PubMed ID: 21921413
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes.
Betteridge DJ; Gibson JM
Diabet Med; 2007 May; 24(5):541-9. PubMed ID: 17367312
[TBL] [Abstract][Full Text] [Related]
17. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease].
Szapáry L; Fehér G
Orv Hetil; 2012 Jun; 153(22):857-60. PubMed ID: 22641260
[TBL] [Abstract][Full Text] [Related]
19. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; MacFadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
N Engl J Med; 2008 Nov; 359(21):2195-207. PubMed ID: 18997196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
